Renalytix AI PLC (LSE:RENX) - Share price


Stock Report

Renalytix AI PLC RENX

Last Price
GBX251.00

Day Change
0.00|0.00%

As of 14/10/2019
17:15:00 BST | GBX
Minimum 15 Minutes Delay.

Last Close251.00p
Day Range244.00 - 258.00
Mkt Cap149.10Mil
52-Wk Range85.00 - 334.00
Yield %-
ISINGB00BYWL4Y04
Volume6,590
P/E-
P/SInfinity
P/CF-23.46

Share Price

Total Returns 11/10/2019

 Chg (%)  
More ...
Renalytix AI PLC- 
FTSE 100 TR GBP6.97
 
Financials
201720182019
More ...
Income Statement
Turnover--0.00
Operating Profit---6.54
Net Profit---5.56
Reported EPS---0.15
Balance Sheet
Current Assets-0.099.40
Non Current Assets-0.0019.52
Total Assets-0.0928.92
Current Liabilities-0.440.76
Total Liabilities---
Total Equity--0.3528.17
Cash Flow
Operating Cash Flow---3.99
Net Change in Cash--9.21
Director Dealings
TradedActionNotifierPriceAmountValue
More ...
20/12/2018PurchaseMr. Christopher Harwood Bernard Mills112.003,1683,548.00
19/12/2018PurchaseMr. Christopher Harwood Bernard Mills103.005,9706,149.00
06/11/2018PurchaseMr. James McCullough120.0016,15019,380.00

Company Profile

Renalytix AI PLC is a developer of artificial intelligence-enabled clinical decision support solutions for kidney disease and costly chronic medical conditions globally. The company's solutions are being designed to make significant improvements in kidney disease risk assessment, clinical care, patient stratification for drug clinical trials, and drug target discovery.

Sector

Diagnostics & Research

Index

Next Event 25/03/2020

Half-Yearly Results
Ratios
Comp
More ...
PER (E)0.00
Div Yld (E)0.00
PEG (E)0.00
ROCE-23.07
Op Mrgn0.00
EPS Grwth0.00
Dividends
PreviousLatest
More ...
Record Datet.b.c.t.b.c.
Ex-Divt.b.c.t.b.c.
Paidt.b.c.t.b.c.
Amnt0.000.00
Directors
More ...
Non-Executive DirectorMr. Christopher Harwood Bernard Mills
Non-Executive Director, ChairmanMr. Julian Baines MBE
Non-Executive DirectorMr. Richard Anthony Evans
Executive Director, Chief Executive OfficerMr. James McCullough
Executive Director, Chief Technical OfficerMr. Fergus Fleming
Non-Executive DirectorDr. Barbara Murphy MD
AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2019 Morningstar. All rights reserved.